JOHN MCGRATH Insider Trading
Get free email notifications about insider trading for JOHN MCGRATH.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of JOHN MCGRATH. JOHN MCGRATH is a CFO in NETWORK EQUIPMENT TECHNOLOGIES INC ($NWK) and a EXC.112.VP CFO in NETWORK EQUIPMENT TECHNOLOGIES INC ($NWK) and a VP & CFO in NETWORK EQUIPMENT TECHNOLOGIES INC ($NWK) and a VP CFO in NETWORK EQUIPMENT TECHNOLOGIES INC ($NWK) and a VP, CFO in NETWORK EQUIPMENT TECHNOLOGIES INC ($NWK) and a Director in ENDWAVE CORP ($ENWV) and a Chief Financial Officer in Atara Biotherapeutics, Inc. ($ATRA) and a EVP & Chief Financial Officer in Atara Biotherapeutics, Inc. ($ATRA).
Address: C/O ENDWAVE CORPORATION 776 PALOMAR AVENUE SUNNYVALE 94085 CA
Companies in which JOHN MCGRATH is an Insider
Atara Biotherapeutics, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of JOHN MCGRATH: EVP & Chief Financial Officer, Chief Financial Officer
Holdings: 91,762 shares
Current Value: $1,381,018
Latest Transaction: Mar 20 2018
$ATRA Market Capitalization: $434.34M
$ATRA Previous Close: $15.05
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
ENDWAVE CORP
Industry: RADIO & TV BROADCASTING & COMMUNICATIONS EQUIPMENT [3663]
Position of JOHN MCGRATH: Director
Holdings: 0 shares
Latest Transaction: Jan 31 2005
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
NETWORK EQUIPMENT TECHNOLOGIES INC
Industry: COMPUTER COMMUNICATIONS EQUIPMENT [3576]
Position of JOHN MCGRATH: VP, CFO, VP & CFO, EXC.112.VP CFO
Holdings: 19,869 shares
Latest Transaction: Nov 05 2009
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of JOHN MCGRATH
Sentiment: All, ATRA, ENWV, NWK
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 20 2018 | ATRA | Atara Biotherapeut ... | MCGRATH JOHN | EVP & Chief Financi ... | Sell | S | 38.83 | 3,000 | 116,490 | 88,762 | 91.8 K to 88.8 K (-3.27 %) |
| Mar 20 2018 | ATRA | Atara Biotherapeut ... | MCGRATH JOHN | EVP & Chief Financi ... | Sell | S | 41.99 | 3,000 | 125,970 | 91,762 | 94.8 K to 91.8 K (-3.17 %) |
| Feb 20 2018 | ATRA | Atara Biotherapeut ... | MCGRATH JOHN | EVP & Chief Financi ... | Option Exercise | M | 0.00 | 5,132 | 0 | 0 | |
| Feb 20 2018 | ATRA | Atara Biotherapeut ... | MCGRATH JOHN | EVP & Chief Financi ... | Sell | S | 48.08 | 2,500 | 120,200 | 94,762 | 97.3 K to 94.8 K (-2.57 %) |
| Feb 20 2018 | ATRA | Atara Biotherapeut ... | MCGRATH JOHN | EVP & Chief Financi ... | Sell | S | 46.93 | 4,000 | 187,720 | 97,262 | 101.3 K to 97.3 K (-3.95 %) |
| Feb 20 2018 | ATRA | Atara Biotherapeut ... | MCGRATH JOHN | EVP & Chief Financi ... | Payment of Exercise | F | 47.05 | 2,926 | 137,668 | 101,262 | 104.2 K to 101.3 K (-2.81 %) |
| Feb 20 2018 | ATRA | Atara Biotherapeut ... | MCGRATH JOHN | EVP & Chief Financi ... | Buy | M | 0.00 | 5,132 | 0 | 104,188 | 99.1 K to 104.2 K (+5.18 %) |